Stability and removal of several statins from wastewater using different treatment technologies by Sulaiman, Saleh et al.
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/279516272
Stability	and	Removal	of	Several	Statins	from
Wastewater	Using	Different	Treatment
Technologies.
Article		in		International	Case	Studies	Journal	·	July	2015
CITATIONS
0
READS
87
7	authors,	including:
Mustafa	Khamis
Al-Quds	University
56	PUBLICATIONS			998	CITATIONS			
SEE	PROFILE
Sabino	Aurelio	Bufo
Università	degli	Studi	della	Basilicata
180	PUBLICATIONS			1,183	CITATIONS			
SEE	PROFILE
Rafik	Karaman
Al-Quds	University
233	PUBLICATIONS			2,820	CITATIONS			
SEE	PROFILE
All	in-text	references	underlined	in	blue	are	linked	to	publications	on	ResearchGate,
letting	you	access	and	read	them	immediately.
Available	from:	Rafik	Karaman
Retrieved	on:	05	September	2016
Impact Factor 3.582   Case Studies Journal ISSN (2305-509X) – Volume 4, Issue 6 – June-2015 
http://www.casestudiesjournal.com  Page 32 
 
Stability and Removal of Several Statins from Wastewater Using Different Treatment 
Technologies. 
Author’s Details: 
Saleh Sulaiman
1,2
, Mustafa Khamis
3
, Shlomo Nir
4
, Filomena Lelario
1
, Laura Scrano
5
, Sabino Bufo
1
 and Rafik 
Karaman*
1,2 
1 Department of  Science, University of Basilicata, Via dell‘Ateneo Lucano 10, 85100, Potenza, Italy, (S.S); (S.A.B.). 2Department of 
Bioorganic Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem 20002, Palestine; 3Department of Chemistry and Chemical 
Technology, Faculty of Science and Technology, Al-Quds University, Jerusalem 20002, Palestine,(M.K.); 4Department of Soil and Water 
Sciences, R.H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel, (S.N.); 
5Department of European Cultures (DICEM), University of Basilicata, Via dell‘Ateneo Lucano 10, 85100, Potenza, Italy,
Abstract: Atorvastatin (ATO), Rosuvastatin (RST) and Simvastatin (SIM) are commonly used drugs that belong to the statin 
family (lowering human blood cholesterol levels) and have been detected as contaminants in natural waters. Stability and 
removal of statins from wastewater produced at Al-Quds University Campus were investigated. Kinetic studies in pure water 
(abiotic degradation), in sludge (biodegradability) and in Advanced Oxidation Processes (AOPs) at room temperature were 
investigated. Heterogeneous photocatalysis using the semi- conductor titanium dioxide (TiO2) has proven to be a promising 
treatment technology for water puriﬁcation. The degradation reactions of the three drugs in wastewater at room temperature 
follow first order kinetics with rate constants of 2.2 x 10
-7
 s
-1
(ATO), 1.8 x 10
-7
s
-1
 (RST) and 1.8 x 10
-6
 s
-1
 (SIM), which are larger 
than those obtained in pure water under the same conditions, 1.9x 10
-8
 s
-1
 (ATO), 2.2x 10
-8
s
-1
 (RST) and 6.2 x 10
-7
 s
-1
 (SIM).  
AOPs process was proposed and applied. TiO2, used as catalyst, owns two important properties: high photo-catalytic activity and 
low cost. Photo-degradation of Atorvastatin was much faster under light irradiation in presence of TiO2 (photocatalysis) (t1/2 = 
1.15 hours, 0.704h
-1
) than under Suntest irradiation (photolysis) (t1/2 = 5.0 hours, 0.165h
-1
). Degradation products were identified 
by LC-MS and LC/MS/MS. The overall performance of the wastewater treatment plant (WWTP) installed in Al-Quds University 
Campus towards the removal of these drugs was assessed showing that more than 90% of spiked ATO, RST and SIM were 
removed. 
In order to evaluate the efficiency of alternative removal methods to replace ultra-filtration membranes, adsorption isotherms for 
the three statins were investigated using both activated carbon and clay-micelle complex as adsorbents and AOP’s as a post 
treatment. The batch adsorption isotherms for the three statins were found to fit Langmuir equation, with larger number of 
adsorption sites and binding affinity for micelle-clay composite compared to activated carbon and filtration experiments of the 
three statins and their corresponding metabolites demonstrated a more efficient removal by micelle-clay filters. 
 
Keywords: Advanced oxidation processes; Photolysis and Photo-catalysis, Activated sludge, Activated charcoal, Micelle – clay 
complex. 
 
 
  
1. Introduction 
 
The substantial and extended use of pharmaceutical and 
personal care products (PPCPs) elucidate their frequent 
occurrence, which comprise a new class of pollutants that have 
been found in a wide range of aquatic environments including 
ambient surface water, groundwater, drinking water, and soil 
[1]-[2], and have high acute toxicity, tendencies to undergo 
bio-accumulation and bio-magnifications. They also have a 
high resistance against degradation and long half-life in the 
environment. 
Nowadays another concern is arising due to pharmaceuticals 
or their metabolites found in environmental samples. The 
presence of pharmaceutical residues in environmental bodies 
has increased the probability of toxicity risks for animals and 
humans in the last years [3]-[5]. It has been reported that the 
aquatic environment can become polluted with 
pharmaceutically active compounds (drugs) at low 
concentrations because of the extensive consumption of 
pharmaceuticals in developed countries [6]-[7]. 
Persistence to biochemical degradation and polar structure, are 
indicated as mainly responsible for the incomplete removal of 
pharmaceuticals during conventional wastewater treatment 
plant [8]-[9] with efficiencies ranging between 60% and 90% 
for a variety of polar compounds [10]-[13].  
To evaluate the efficiency of different traditional and 
innovative tools for the elimination of pharmaceutical 
residues, a series of water purification experiments were 
performed by using the WWTP installed at the Al-Quds 
University in Palestine as indicated in Figure 1 (appendix A), 
which includes sequential units as activated sludge (AS), ultra-
filtration (UF), granular activated charcoal (GAC) and reverse 
osmosis (RO) [14]. 
Problems arising from the management of such a plant can be 
referred to the capability of the AS unit to favor the bio-
degradation of organic pollutants as well as the fouling 
phenomenon affecting membrane units, which must be often 
replaced with high costs. 
The present work reporting about the efficiency of advanced 
wastewater treatment technologies adopted in the Al-Quds 
WWTP for the removal of ‗Atorvastatin‘ (ATO), Rosuvastatin 
(RST) and Simvastatin (SIM) which were used as model 
pharmaceutical compounds due to their large consumption in 
many Countries.  
Aiming at the assessment of bacterial culture, which normally 
develops in the AS unit of Al-Quds WWTP, the stability of 
ATO, RST and SIM in pure water as well as in activated 
sludge collected from the plant were investigated and their 
degradation products were identified. 
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Finally, in order to check for different tools to be used instead 
of ultra-filtration membranes, the effectiveness of micelle-clay 
(MC) filter for removing ATO, RST and SIM was ascertained 
and compared to a filter filled with granular activated 
charcoal. Besides, the adsorption equilibrium parameters and 
the adsorption Langmuir coefficients were determined using 
both micelle-clay and fine powder activated charcoal (FAC) as 
adsorbent materials. In order to achieve a complete 
elimination of recalcitrant organic residue AOP‘s was used as 
a post treatment. 
Advanced oxidation processes (AOPs) [15] constitute an 
alternative to filtration methods in removing organic matter 
from wastewater. The mechanism of AOPs is the generation of 
highly reactive free radicals such as hydroxyl radical (OH•) 
which is effective in destroying organic chemicals. Photo-
catalytic oxidation is one of the most effective clean 
technologies able to reduce/remove contaminants from 
wastewater and drinking water. [16] A most used as photo-
catalyst is TiO2. This semiconductor can be used in a wide pH 
range, being able to produce electronic transitions by light 
absorption in the near ultraviolet range. TiO2 is also 
characterized by its low cost, its high photo-catalytic activity, 
and its resistance to photo-corrosion. [16] 
Atorvastatin (ATO, structure 1, Figure 2), [(3R,5R)-7-[2-(4-
Fluoro-phenyl)-4-(phenylcarbamoyl)-5-isopropyl-3-phenyl-
pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid, is one of the most 
prescribed drugs.[17] Recently it has been observed that ATO, 
like other statins, can be efficient against Alzheimer‘s 
disease.[17] Less than 5% of a dose of ATO is recovered in 
urine following oral administration. The presence of ATO in 
sewage effluents and surface waters has been observed in 
concentration levels of µg L
-1
. [18] 
Pharmacokinetic studies have shown that, after oral 
administration, ATO was rapidly metabolized into two active 
hydroxy metabolites (2-hydroxy-ATO and 4-hydroxy-ATO) 
and three inactive lactone metabolites.[19]-[20] However, the 
lactones were unstable as they hydrolyzed readily to their 
original acid forms. In contrast, RST was found not to be 
extensively metabolized, as 77% of it was excreted unchanged. 
[21] Approximately 90% of the non-metabolized RST was 
recovered in feces, with the remaining 10% in urine. Two 
minor metabolites, the RST-5S-lactone (RSTL) and the N-
desmethyl RST, were identified by LC-NMR and LC–MS/MS 
in the same study. [21] 
Atorvastatin was found to undergo a self-sensitized photo 
oxygenation by sunlight in water. [22] The main 
photoproducts, isolated by chromatographic techniques, were 
identified by spectroscopic means. They present a lactam ring 
arising from an oxidation of pyrrole ring and an alkyl/aryl 
shift. A mechanism involving singlet oxygen addition and an 
epoxide intermediate was suggested. [22] 
Rosuvastatin, bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-
[methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S)-3,5-
dihydroxyhept- 6- enoic acid] (RST, structure 2, Figure 2, 
Appendix A), decreases the production of LDL cholesterol by 
blocking the action of the enzyme HMG-CoA reductase in the 
liver. This decreases the amount of cholesterol in the liver 
cells, which causes them to take up LDL cholesterol from the 
blood. The decreased cholesterol production and increased 
removal of LDL cholesterol from the blood ultimately results 
in lowered blood cholesterol levels.[23]-[24] In the 
pharmacokinetic study of RST, RSTL (structure 4, Figure 1, 
Appendix A) was identified as one of the minor 
metabolites.[21] 
Simvastatin, is (+) (1S,3R,7S,8S,8αR)-1,2,3,7,8,8α-hexa-
hydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-
oxo-2H-pyran-2-yl]-1-naphthyl-2,2-dimethyl butanoate (SIM, 
structure 3, Figure 2, Appendix A), is derived synthetically 
from a fermentation product of Aspergillu sterreus.[25] After 
oral ingestion, Simvastatin, which is an inactive lactone, is 
hydrolyzed to the corresponding β-hydroxyacid form. The 
latter is a potent inhibitor of 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase, an essential enzyme 
involved in the in vivo synthesis of cholesterol. [26]- [27] 
The goals of this study were (i) to explore the efficiency of the 
integrated advanced wastewater treatment technology installed 
at Al-Quds WWTP towards the removal of Atorvastatin, 
Rosuvastatin and Simvastatin and their metabolites from 
spiked wastewater samples; (ii) to show the behavior of 
Atorvastatin upon exposure to TiO2 photodegradation (iii) to 
evaluate the degradation kinetics of the above mentioned 
compounds in water and sludge, and identify the 
biodegradation products; (iv) to determine the ability of 
micelle-clay composite and activated carbon towards removal 
of these drugs by adsorption from aqueous solutions. 
Furthermore, adsorption kinetics and adsorption isotherms will 
be evaluated and fitted to Langmuir equations. The micelle-
clay composite which was used in this study is positively 
charged, has large surface area and includes large hydrophobic 
domains. Micelle-clay composites have already been proven 
useful in the removal of about 20 neutral and anionic 
pollutants. [28] 
 
 
 
      2.Experimental 
2.1 Materials and Equipments 
2.1.1 Materials. 
All chemicals were of analytical grade. The clay used was 
Wyoming Na- montmorillonite SWY-2 clay; obtained from 
the Source Clays Registry (Clay Mineral Society, Colombia, 
MO, USA). Quartz sand (grain size 0.8—1.2 mm) was 
obtained from Negev industrial minerals (Israel). 
Octadecyltrimethylammonium (ODTMA) bromide was 
obtained from Sigma Aldrich. Pure ATO, RST and SIM were 
obtained from Birzeit Pharmaceutical Company (Palestine) 
with 99% purity, and all were used as received. Fine powder 
activated charcoal (FAC) with particle size ≤ 60.0 µm, and 
granular activated charcoal (GAC) with particle size ≤ 700.0 
µm were obtained from Sigma (Sigma Chemical Company, 
USA). The powder was used for batch adsorption 
experiments while the granules were used in column 
experiments. Magnesium sulfate anhydrous, potassium 
dihydrogen phosphate as well as methanol, acetonitrile and 
deionized water for analysis (HPLC grade) were purchased 
from Sigma Aldrich (Munich, Germany). High purity diethyl 
ether (> 99%) was purchased from Biolab (Israel). For 
sample enrichment and purification SPE 1g C-18 6 mL 
disposable cartridges (Waters, Milford, MA, USA) were 
used. 
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TiO2 P-25 (anatase/rutile = 3.6/1), surface area 10 m
2
/g, non-
porous) was performed from Degussa. 
Activated sludge used in the stability test was obtained from 
the Advanced Wastewater Treatment Plant, located at Al-
Quds University-Palestine and was described in detail 
elsewhere. [28] 
 
2.1.2 Equipments. 
Samples were shaken using Big Bill, (Banstaed/ Themolyne, 
USA).  The disappearance of ATO, RST and SIM were 
determined by using a high pressure liquid chromatography 
system model 2695 HPLC from Waters (Israel), equipped 
with a Waters 2996 Photodiode array. Data acquisition and 
control were carried out using Empower ™ software (Waters, 
Israel). Analytes were separated on a 4.6 mm x150 mm C18 
XBridge® column (5 μm particle size) used in conjunction 
with a 4.6 mm, 20 μm, XBridge® C18 guard column. 
 
HPLC conditions: mixture of 1% H3PO4: acetonitrile (1:1; 
v/v) as mobile phase, flow rate of 1.5 mL min
-1
; UV detection 
at a wavelength of 238 nm. Acrodisc® syringe filters with 
GHP membrane (hydrophilic polypropylene 0.45μm 
porosity) from Waters were always used for all analytical 
filtration requirements. [29] 
 
The identification of ATO, RST and SIM degradation 
products were performed using a liquid chromatography 
system coupled to a hybrid linear quadrupole ion trap (LTQ) 
– Fourier-transform ion cyclotron resonance (FT-ICR) mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany). 
 
Analyses were performed by using the same column in an 
isocratic mode with two solutions, solution A: water with 
formic acid (0.1% v/v) and solution B: acetonitrile (100% 
v/v) [35:65] at ambient temperature at a flow rate of 1.0 
mL/min, which was split 4:1 after the analytical column to 
allow 200 µl min
-1
 to enter the ESI source. Negative and 
positive ion ESI-MS was used for the detection of 
compounds of interest. Mass spectrometric conditions were 
optimized by direct infusion of standard solutions. The 
instrument was tuned to facilitate the ionization process and 
achieve the highest sensitivity. The MS detector was tuned 
whenever the solvent flow rate conditions were changed, and 
the electrospray voltage, heated capillary temperature and 
voltage, tube lens voltage, sheath gas flow rate and auxiliary 
gas flow rate were optimized until the ion transmission was 
maximized. Full-scan experiments were performed in the ICR 
trapping cell in the range m/z 50–1000. Mass-to-charge ratio 
signals (m/z) were acquired as profile data at a resolution of 
100,000 (FWHM) at m/z 400. Data acquisition and analyses 
were accomplished using the Xcalibur software package 
(version 2.0 SR1 Thermo Electron). The simplest method to 
identify analytes by eXtracted Ion Chromatograms (XICs) 
was used. XIC collects ion intensities falling within a given 
mass-to-charge-ratio window and appears to be the method of 
choice for mass analysis leading to very simple 
chromatograms. The reduction of interferences in the XICs 
significantly facilitates the identification of putative 
metabolites. Data were collected in full MS scan mode and 
processed post-acquisition, to reconstruct the elution proﬁle 
for the ions of interest, with a given m/z value and tolerance. 
The chromatographic raw data were imported, elaborated and 
plotted by Sigma Plot 10.0 (Systat Software, Inc., London, 
UK). 
The advanced wastewater treatment plant employed in this 
study is located at Al-Quds University-Palestine and was 
described in detail elsewhere. [28] Normally, the effluent 
from this plant is recycled for the irrigation of plants cropped 
in the field of university Campus. 
2.2 Methods 
2.2.1 Characterization of wastewater used. 
The wastewater was characterized before the experiments 
according to the American Public Health Association 
procedures [30]-[31] by performing measurements listed in 
Table 1, appendix B. 
 
2.2.2 Efficiency of WWTP for ATO, RST and SIM 
removal. 
The efficiency of different treatment units was determined by 
spiking separately the secondary effluent with 1.0 mg L
-1
 of 
ATO, RST and SIM in the activated sludge reservoir (1000 
L). Samples were collected from different locations of the 
WWTP as depicted in Figure 1, Appendix A. SPE-C18 
disposable cartridges were used to pre-concentrate 10 mL of 
each sample by adsorption of analytes. A part (20 µL) of the 
methanolic solution eluted from SPE cartridge was injected 
into the HPLC, and analyzed using the same conditions for 
the determination of ATO, RST and SIM. Recovery tests 
were performed using triplicate solutions of the three 
substances, and values ranging from 98% to 102% were 
obtained. 
 
2.2.3 Stability of ATO, RST and SIM. 
Stability studies of ATO, RST and SIM were performed 
using 100 mg L
-1
 solutions in pure water, or activated sludge 
taken from the secondary treatment stage of the WWTP 
installed at Al-Quds University. At specific time intervals (0 
to 35 days) samples were collected from the solutions 
(maintained under continuous orbital shaking), filtered, and 
analyzed by HPLC. The degradation by-products of ATO, 
RST and SIM were quantified using liquid 
chromatography/Fourier-transform ion cyclotron 
resonance/mass spectrometry (LC/FT-ICR MS). 
 
2.2.4 Micelle-clay complex preparation. 
The ODMTA micelle-clay complex was prepared by mixing 
a smectitic clay- mineral (montmorillonite) with the cationic 
surfactant octadecyltrimethylammonium (as bromide salt) at 
multiples of 10 g L
-1
 (clay) and 12 mM (ODTMA, 5 in Figure 
2, Appendix A) as described elsewhere. [28] The obtained 
complex, which has net positive charge and includes 
hydrophobic regions, is capable of efficiently binding neutral 
and negatively charged organic molecules .[30]-[34] 
 
2.2.5 Batch adsorption experiments. 
Batch adsorption experiments were carried out on ATO, RST 
and SIM at different concentrations. Experiments were 
performed in 250 mL Erlenmeyer flasks containing 200 mg 
of either micelle-clay complex or fine powder activated 
charcoal (FAC). 100 mL of each drug solutions having 
known initial concentration were then introduced into each 
flask. The flasks were shaken in an oscillating shaker for 
three hours at room temperature, and then 2.0 mL portions 
were filtered using 0.45 μm filters. Equilibrium 
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concentrations of ATO, RST and SIM were then obtained by 
HPLC, using the conditions reported above. The retention 
times of ATO, RST and SIM were 6.6, 3.7 and 3.2 minutes, 
respectively. 
 
2.2.6 Column filtration experiments. 
Column filtering experiments were performed using 50/1 
(w/w) mixtures of quartz sand and either ODTMA-clay 
complex, or granular activated charcoal (GAC), 20 cm 
layered in borosilicate columns of 25 cm length and 5 cm 
internal diameter. Each column contained 13 g of complex, or 
GAC. The bottom of the column was covered with 3 cm layer 
of quartz sand. Quartz sand was thoroughly washed by 
distilled water and dried at 105 °C for 24 hours before its use. 
Solutions in pure water (1 L each) containing different ATO, 
RST and SIM concentrations (0.01, 1, 10, and 100 mg L
-1
) 
were passed through either micelle-clay or GAC columns 
(one column for each solution). In all cases the flow rate was 
2.0 mL min
-1
. Eluted fractions were collected in all column 
experiments and analyzed. 
All experiments reported were performed in three replicates 
and average values and standard deviations were calculated. 
 
2.2.7 Photochemical and Photocatalytic experiments. 
Photochemical and photocatalytic experiments were 
conducted by using Suntest CPS Solar Simulator (Heraeus 
Instruments, Germany) equipped with a xenon lamp, with a 
temperature sensor and a water-cooling circuit. The xenon 
lamp was filtered by an optically stable borosilicate UV filter 
(Atlas Material Testing, France) delivering a light emission 
spectrum similar to that of the sun. 
A stock solution (0.1mM) of Atorvastatin pure standard in 
water was prepared and kept in the darkness at + 4°C. 
Calibration and working solutions of Atorvastatin were 
prepared when used by dilution from stock solution. 
 
Kinetic behavior of Atorvastatin was performed by using 
HPLC Waters 2695 equipped with a photodiode array. Data 
acquisition and control were carried out using Empower ™ 
software (Waters: Israel). Analytes were separated by using a 
C18XBridge® column (4.6 mm x150 mm, 5 μm particle 
sizes). pH meter HM-30G (TOA electronics™) was used to 
control the samples pH value. 
 
3. Results and discussion 
3.1 Calibration curves 
Linearity of the proposed analytical method was verified by 
analyzing standard solutions in the range of 0.1 - 100 mg L
-1
 
for ATO, RST and SIM in pure water. The calibration curves 
were obtained using HPLC method with calculated regression 
coefficient ranging from 0.9998 to 0.9999. The 
reproducibility of triplicate subsequent injections ranged 
from 98.4% to 99.6%, depending on the sample 
concentration and type of analytes. The reproducibility of 
morning/evening injections on the basis of 6-hours elapsed 
time ranged from 97.5% and 98.0%, and was also affected by 
the concentration and type of analytes. Correction 
coefficients were used for experimental samples. 
 
Calibration curves and reproducibility trials were repeated; 
preparing new calibration solutions by using wastewater 
taken from the activated sludge reservoir of Al-Quds WWTP. 
Results suffered of a minor accuracy due to the variability of 
recovery percentages. Anyway, the determination coefficients 
of calibration curves were 0.9997 for ATO, 0.9995 for RST 
and 0.9999 for SIM. The limit of detection, based on a 
signal/noise of 3, was 0.03 mg L
-1
 for ATO and RST, and 
0.02 mg L
-1
 for SIM. The limit of quantifications, based on a 
signal/noise of 10, was 0.08 mg L
-1
, 0.08 mg L
-1
 and 0.06 mg 
L
-1
 for ATO, RST and SIM, respectively. 
3.2 Wastewater characteristics 
Table 2, Appendix B, summarizes the chemical, physical and 
biological characteristics of wastewater sampled from the 
activated sludge reservoir of Al-Quds WWTP. Table 2 
reveals that the wastewater contained high amounts of 
suspended solids and large populations of bacteria, which are 
responsible for fouling phenomena affecting ultra-filtration 
and reverse osmosis membranes. Moreover, high values of 
electrical conductivity and total dissolved solids, are typical 
for municipal wastewaters, and should be reduced if WWTP 
effluents are re-used for crop irrigation purposes. 
3.3 Efficiency of WWTP for ATO, RST and SIM removal 
The efficiency of WWTP at Al-Quds University for the 
removal of ATO, RST and SIM was studied. The activated 
sludge reservoir (site 1 in Figure 1; Table 3) was separately 
spiked with ATO, RST or SIM at concentration of 1.0 mg L
-
1
, which is an amount close to environmental values reported 
in the literature.[35]-[36] Samples were taken from different 
collecting sites of WWTP as described in Figure 1. 
Analytical results of water effluent from the hollow fiber 
ultra-filtration membrane (UF-HF) indicated that ATO, RST 
and SIM were about 84.6%, 69.2% and 73.6% removed at 
this stage, respectively, whereas about 100% of ATO, RST 
and 90.7% of SIM were removed after passing the spiral 
wound (UF-SW) membrane (Table 3, Appendix B). Besides, 
RST was completely removed in the effluent from GAC 
filter. However, it should be outlined that the concentration of 
ATO, RST and SIM influent in the treatment units were 
diminishing along their sequence. This resulted in 100% 
removal by GAC filter, whose influent water contained only 
0.067 mg L
-1
 of RST, on average, after the passage through 
the UF filters. This finding made unnecessary the use of 
reverse osmosis for any further purification. Nevertheless, the 
advanced technology adopted in the WWTP of Al-Quds 
University did not overcome a problem common to all plants: 
the production of brine, in which a large portion of the 
contaminants ends up being concentrated there. For this 
reason additional methods of water filtration and purification 
were experimented. 
 
3.4 Stability of ATO, RST and SIM in pure water and in 
sludge 
Since many pharmaceuticals might undergo degradation upon 
their standing in aqueous medium and sludge environment 
[36]-[37], kinetics studies on degradation of Atorvastatin, 
Rosuvastatin and Simvastatin in pure water and activated 
sludge conditions have been undertaken. Table 4, Appendix 
B, summarizes the hydrolysis results of the drugs in activated 
sludge and pure water at room temperature. For brevity we 
show the detailed results only for Atorvastatin (A) (Figure 3, 
Appendix A) and Simvastatin (B) (Figure 3, Appendix A). 
The results in Table 4, Appendix B, indicate that the rates of 
degradation for ATO, RST, and SIM in sludge are about 12-, 
8- and 3-fold faster than in pure water, respectively. The rate 
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of degradation of SIM in sludge is about an order of 
magnitude faster when compared with ATO and RST, where 
the ratio is about 30-fold in water. The higher rate of SIM 
degradation compared to ATO and RST stems from the fact 
that SIM exists as a lactone moiety which is readily 
hydrolyzed to the corresponding carboxylic acid form in the 
presence of acid or base catalysis, whereas ATO and RST 
exist in the free carboxylic acid forms. 
The accelerated degradation in sludge compared to that in 
pure water can be attributed to bioactivity of the activated 
sludge. The morphological characterization of bacterial 
community in Al-Quds activated sludge allowed to identify 
many bacterial species: Escherichia coli, Enterobacter 
sakazakii, Citrobacter freundii, Pseudomonas aeruginosa, 
Klebsiella pneumonia, Enterobacter cloacae, Enterobacter 
amnigenus, Enterobacter aerogenes, Salmonella spp., and 
Serratia liquefaciens. Further challenge will be the isolation 
of strains constituting the bacterial colonies, aiming at the 
identification of the more active strains capable of utilizing 
the pharmaceutical molecules as energy source. 
 
Literature survey on the stability and degradation of SIM 
indicates that the drug can undergo metabolic degradation in 
humans.[38] Upon incubation of SIM with liver microsomal 
preparations from human donors, four major metabolic 
products were formed (3*-hydroxy SIM, 6*-exomethylene 
SIM, 3*,5*-dihydrodiol SIM, and the active hydroxy acid, 
SIMA), together with several minor unidentified 
metabolites.[38] Based on four different in vitro approaches, 
namely 1) correlation analysis, 2) chemical inhibition, 3) 
immune inhibition, and 4) metabolism by recombinant human 
P450, it is concluded that CYP3A is the major enzyme 
subfamily responsible for the metabolism of SIM by human 
liver microsomes.[38] Similar results were obtained by 
Robert et al. (2003)[39], who showed that CYP3A4 was the 
main enzyme involved in ATO metabolism resulting in the 
major metabolite ortho-hydroxy ATO and in active 
metabolites ATO lactone and ortho-hydroxy ATO lactone 
(Figure 4, Appendix A). These results are in agreement with a 
study by Liu et al. (2008)[40] who showed that ATO 
administered in its calcium salt active form was converted 
into active ATO acid, which is then metabolized into two 
other active metabolites, para-hydroxy ATO (p-ATO), and 
ortho-hydroxy ATO (o-ATO). These three active compounds 
are subsequently equilibrated with their corresponding 
lactone forms at the ratio of approximately 1:1[40]. Jani et al. 
(2010) [41] found that ATO in plasma can be metabolized by 
CYP3A4 to two hydroxylated metabolites, o- hydroxyl 
atorvastatin and p-hydroxyatorvastatin (Figure 4, Appendix 
A). 
 
RST is a new generation of HMG-CoA reductase inhibitor, 
which exhibits some unique pharmacologic and 
pharmacokinetic properties. It has low extra hepatic tissue 
penetration, low potential for CYP3A4 interaction and 
substantial LDL-C lowering capacity and therefore has 
distinct advantages.[42] Metabolism of RST by cytochrome 
p450 (CYP) appears to be minimal and is principally 
mediated by the 2C9 enzyme, with little involvement of 3A4; 
this finding is consistent with the absence of clinically 
significant pharmacokinetic drug-drug interactions between 
RST and other drugs known to inhibit CYP enzymes.[43] 
The major metabolite of RST is N-desmethyl RST (active) 
via CYP450 2C9. Greater than 90% of activity is due to N-
desmethyl RST. Clearance is not significantly dependent on 
CYP450 3A4.[42] Monitoring the derivative substances 
arising from the degradation of ATO, RST and SIM in the 
activated sludge indicated that ATO underwent degradation 
to five by-products, whereas RST and SIM gave rise to only 
one derivative, respectively, as identified by mass 
spectrometric analysis. Extracted ion chromatograms (XICs) 
of the 35 days biodegraded sample are shown in Figure 5, 
Appendix A. The benefit of using very selective extracted ion 
chromatograms by FTICR MS, generated with a tight mass-
to-charge ratio window of ±0.0010 units around each selected 
protonated or deprotonated molecule (i.e. [M+H]+ or [M-H]-  
±1.0 mDa), greatly reduced the signal complexity of the total 
ion current trace ( Fig. 5(b)) allowing to completely 
characterize all degradation products. 
 
Five major biodegradation products for Atorvastatin 
(Fig.5(a)B, exact [M-H]- m/z 557.24572) were found at 
retention times 7.5(6), 5.2(7), 4.3(8), 4.5(9) and 6.0(10) 
minutes, corresponding to compounds with exact [M-H]- m/z 
ratios 589.23555 (6, Fig.5(a)D), 573.24064 (7, Fig.5(a)C), 
547.18860 (8, Fig.5(a)E), 545.17295 (9, Fig.5(a)F), 
513.21951(10, Fig.5(a)H). Based on the accurate m/z ratios 
of deprotonated molecules, their retention times, and relevant 
literature [41], we propose for Atorvastatin biodegradation 
the structures reported in Figure 6, Appendix A. The major 
metabolites resulted the compound (7), the para-hydroxy 
Atorvastatin, C33H35FN2O6, with exact [M-H]- m/z 573.24064 
(error 0.6 ppm ). Ortho, para-dihydroxyatorvastatin was, also, 
recognized at exact deprotonated m/z ratio 589.23555 (error 
1.2 ppm). The peaks belong to (8), (9) and (10) can be 
attributable to compounds obtained from losses of -
CH3COOH or isopropyl group from other biodegraded, 
oxidized products. 
 
Rosuvastatin (Fig.5 (b) B, exact [M-H]- m/z 480.16101) has 
one of major biodegradation products at retention time of 
5.2(5) minutes (Fig.5 (b) E). Based on the accurate m/z ratios 
462.15098 and relevant literature [43] we suggest the 
structure of the metabolite as shown in Figure 2 (structure 4). 
Other compounds derived from hydroxylation or 
polihydroxylation  (Fig 5 (b) C and D) showing an accurate 
[M-H]- ratio at m/z 496.15614 (exact m/z 496.15592, error 
0.4 ppm) and 514.16660 (exact m/z 514.16649, error 0.2 
ppm) and attributable at compounds with molecular formula 
C22H28FN3O7S and C22H30FN3O8S , respectively, which were 
also found in the biodegraded solution of Rosuvastatin. For 
Simvastatin (Fig.5 (c), exact [M-H]- m/z 573.24064)  one 
major biodegradation product was formed at retention time of 
9.1 (11) minutes. Based on the accurate [M-H]- m/z ratio 
435.27560 (error 0.9 ppm) and relevant literature [38], we 
propose the structure of SIM metabolite as shown in Figure 6 
(11). Interestingly, accurate mass data of biodegraded 
products, as protonated or deprotonated molecules, with a 
mass error lower than +1.2 ppm was found, indicating a very 
good mass accuracy. 
It is worth noting, that no reports have been published on 
biodegradation of ATO, RST and SIM in wastewater. 
 
 
3.5 Adsorption isotherms 
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The adsorption of ATO, RST and SIM at several initial 
concentrations on micelle-clay complex and activated 
charcoal was investigated. Equilibrium relationships between 
adsorbent and adsorbate can be described by Langmuir 
adsorption isotherm [44], represented by equation (1): 
 
 Ce/Qe=1/(kQmax)+Ce/Qmax                                       (1) 
 
where Ce (mg L
-1
) is the equilibrium concentration of the 
drug in the solution, Qe (mg g
-1
) is the equilibrium mass of 
adsorbed drug per gram of complex or activated charcoal, K 
(L mg
-1
) is the Langmuir binding constant, and Qmax (mg g
-
1
) is the maximum mass of drug removed per gram of 
complex. 
 
Data fitted well the Langmuir equation for ATO, RST and 
SIM giving R
2
 = 0.9873, 0.9748 and 0.9568 for activated 
charcoal and 0.9223, 0.9408 and 0.9154 for the micelle-clay, 
respectively (Table 5, Appendix B). The values of K and 
Qmax parameters for the adsorption isotherm obtained using 
micelle-clay complex were larger than those correspond to 
activated charcoal, suggesting the former as the better 
adsorbent for ATO, RST and SIM removal. 
 
3.6 Filtration results 
ATO, RST and SIM solutions were passed separately through 
filtering columns, which included the micelle-clay complex 
or activated charcoal mixed with excess sand at 1:50 ratios 
(w/w). The results (Table 6, Appendix B) indicate a 
significant advantage of the micelle-clay filter in removing 
ATO, RST and SIM compared to the removal by activated 
charcoal. The removal efficiency of filters filled with 
activated charcoal and sand was acceptable only for the 
lowest ATO, RST and SIM concentrations, whereas the 
micelle clay system removed the drugs completely at the 
higher concentrations. This finding is in line with the 
adsorption isotherms, which showed that the micelle-clay 
complex was more efficient than activated charcoal in 
adsorbing ATO, RST and SIM from water. 
Previously reported experiments demonstrated the poor 
capability of activated carbon filters towards removing of 
anionic and certain neutral pollutants [32]-[34]. 
 
Polubesova et al. [32] found very efficient removal of three 
anionic pollutants (imazaquin, sulfentrazone, sulfosulfuron) 
and 4 neutral pollutants (alachlor, acetochlor, chlorotoluron 
and bromacil) by micelle –clay complexes in aqueous 
dispersions. In another study [33] column filters filled with a 
mixture of quartz sand and micelle–clay complex provided 
very efficient result for the retention of tetracycline and 
sulfonamide pharmaceuticals from wastewater. 
Zadaka et al. [34] tested column filters with either a mixture 
of quartz sand and organic micelle – montmorillonite or 
zeolite; both filters were capable to well remove ethylene 
dibromide, anionic pollutants as sulfosulfuron, imazaquin and 
sulfentrazone, and neutral compounds as bromacil and 
chlorotoluron from aqueous environments; in contrast a filter 
filled with the same weight of activated carbon and sand 
removed only partially these pollutants. 
In a recent paper, Karaman et al. [28] showed that micelle-
clay filters are more efficient towards removal of diclofenac 
potassium from wastewater than activated carbon. Moreover, 
Khamis et al. [27] concluded that the incorporation of 
micelle-clay filters in sewage treatment systems with loose 
tertiary capability can be a promising technology. More 
recently, Khalaf et al. [45] suggested that the integration of 
clay-micelle complex filters in existing WWTPs may be 
helpful for improving removal efficiency of recalcitrant 
residues of non steroid anti inflammatory drugs (NSAIDs). 
 
It can be argued that in addition to ATO, RST and SIM 
residues wastewater usually includes other recalcitrant 
organic pollutants [46]-[50]. In such cases GAC filters can be 
used as first stage tertiary process to remove the majority of 
neutral pollutants, and additional micelle-clay filters can be 
adopted as second stage to eliminate anionic pollutants, and 
neutral compounds not retained by GAC filters. 
 
3.7 Photolysis and Photocatalysis processes of 
Atorvastatin 
 
Table 7, Appendix B, shows kinetic parameters of the 
photochemical reactions, considering three replicates for each 
experiment. In all cases, photo-reactions of the first order 
resulted, and the half-life of Atorvastatin under light 
irradiation was always lower than Atorvastatin under 
photocatalysis .The pure standard solutions used as a control 
in the darkness did not show any significant degradation 
during the experiment. 
 
The results of photolysis and photocatalysis of ATO in 
aqueous solution are shown in Figure 7, Appendix A. A 
complete removal of this species was achieved, at the 
adopted experimental conditions, with half life of 5 hours 
under photolysis and 1.15 hours of irradiation under photo 
catalysis conditions, with the formation of four major 
intermediates. 
It is known, that TiO2 is a strong oxidizing agent. The band 
gap illumination of a semiconductor particle suspended in 
water causes electronic transitions from the valence band to 
the conduction band, leaving holes in the former. These 
electrons and holes then either migrate to the particle surface 
and become involved in redox reactions or they recombine 
and simply liberate heat. Conduction- band electrons are 
consumed in reactions that reduce oxidants while holes are 
filled via oxidation reactions. Hydroxyl radicals are generated 
by the oxidation of water at the valence band of TiO2. [51]- 
[53] 
The OH• radicals formed on the illuminated semiconductor 
surface are very strong oxidizing agents with an oxidation 
potential of 2.8 V. These can easily attack the adsorbed 
organic molecules or those located close to the surface of the 
catalyst, thus, at the final stage, leading to their complete 
mineralization (Figure 8, Appendix A). All photoproducts 
derived from both experiments were identified either by 
comparison of the mass spectra and retention times with 
literature spectra and by accurate masses. 
Behnaz et al.[2011] [54] found that under the experimental 
conditions used, at high atorvastatin concentration (35.8 mM) 
the contribution of singlet oxygen (
i
O2) to the 
photodegradation of atorvastatin in natural waters was higher 
than that of hydroxyl radical, and accounted for up to 23% of 
the loss in aqueous solutions. Whereas, at a concentration of 
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35.8 nM,
•
O2 (and »OH) both played a minor role in the 
removal of this compound. 
Flavio et al. [2006] [55] found that Atorvastatin undergoes a 
self-sensitized photo oxygenation by sunlight in water. The 
main photoproducts, isolated by chromatographic techniques, 
have been identified by spectroscopic means. They present a 
lactam ring arising from an oxidation of pyrrole ring and an 
alkyl/aryl shift. 
 
Figure 9, Appendix A, shows the probable intermediates 
metabolites structures for photo chemical of atorvastatin, 
where more study on those compounds is in progress. 
Compound 12 showed a molecular peak at m / z  575.2046 
[M+H]+ suggesting a molecular formula C33H34FN2O6. 
Compound 13 showed a molecular peak at m / z  587.2355, 
[M+H] + in the ESI-MS spectrum suggesting a molecular 
formula C34H35FN2O6. All the previous results agree with 
[54]. Cermola et al., [2006] [56] suggest that all atorvastatin 
photoproducts characterized arise from an oxidation of 
pyrrole ring and an alkyl/aryl shift with formation of a lactam 
ring or via lactonization and cyclization, respectively. [56] 
 
4. Conclusions 
The stability studies of Atorvastatin, Rosuvastatin and 
Simvastatin revealed that the three statins were unstable both 
in water and sludge environments. In addition, it was found 
that the rate of degradation in sludge was higher than in water 
due to the presence of many bacterial species having a variety 
of enzymes which can catalyze the degradation processes for 
the mentioned three statins. It should be worth noting that the 
higher degradation rate found for Simvastatin compared to 
that of Atorvastatin and Rosuvastatin can be attributed to the 
relatively unstable lactone ring present in Simvastatin. 
The filtration study involving an advanced wastewater 
treatment plant utilizing ultrafiltration, activated carbon and 
reverse osmosis demonstrated that activated carbon and RO 
are efficient in removing the commonly used statins: 
Atorvastatin, Rosuvastatin and Simvastatin from wastewater. 
However, fouling problems due to the high bacterial load in 
the sludge and the production of brine cannot be avoided. For 
this reason a filter based on micelle-clay complex, 
(ODTMA)-montmorillonite, was tested and found to be very 
efficient in removing all three statins from solution in the 
mgL
-1
 or µgL
-1
 ranges. The large effectiveness and removal 
capacity are due to a relatively high affinity of adsorption of 
the anionic Atorvastatin, Rosuvastatin and Simvastatin by the 
large number of positively charged and hydrophobic sites of 
the micelle-clay complex based on ODTMA. Furthermore, 
pilot experiments are needed to evaluate if filters based on 
micelle-clay could be included in WWTPs aiming at the 
reduction of membrane‘s use or at enhancing their efficiency 
and prolonging their life. 
In conclusion, atorvastatin has been found to be sensitive to 
sunlight. So it was noticed that photolysis process has the 
ability to eliminate this drug from water, while photo 
catalysis shows much more significant degradation. 
Both photo-degradation processes have followed a 1
st
 order 
kinetic while the t1/2 ranging from 1.15 under photo-catalysis 
to 5.0 h under photolysis. 
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Appendix A 
 
 
 
Figure 1: Flow diagram schematizing the WWTP at Al-Quds University. Sampling sites are indicated by numbers. UF/HF, hollow 
fiber ultrafiltration membrane; UF/SW, spiral wound ultrafiltration membrane; RO, reverse osmosis; GAC, granular activated 
charcoal filter. 
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Figure 2: Chemical structures of Atorvastatin (1), Rosuvastatin (2), Simvastatin (3) and Rosuvastatin lactone (RSTL) (4), 
Octadecyltrimethylammonium ion (5). 
 
Figure 3: Kinetics of ATO (A) and SIM (B) degradation in pure water (plot a) (♦) and activated sludge (plot b) (■). Data are 
reported as natural logarithm of concentrations (C(t)) vs. time. Initial concentration (C(0)) = 100 mg L
-1
. Plotted values are the 
means of three replicates; bars represent the standard deviations calculated for each average value, T = 25 °C. 
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Figure 4: Atorvastatin metabolism to ortho or para hydroxy atorvastatin by CYP3A4. 
 
                                                                        (b) 
0 
4e+6 
A 
0 
2e+6 
Intensity (cps) 
0 
2e+4 
0 
4e+3 
Time (min) 
-1 0 1 2 3 4 5 6 7 8 9 10 11 12 
0 
5e+3 
 m/z= 480.16001-480.16201 
 m/z= 496.15492-496.15692  
 m/z= 514.16549-514.16749  
 m/z=462.14944-462.15144 
B 
C 
D 
TIC 
4.1 
3.9 
E 5.2 
3.6 
4.1 
                                                    (a) 
0 
3e+6 
A 
0 
2e+6 
0 
2e+5 
0 
2e+3 
0 
1e+4 
 m/z= 557.24472-557.24672 
 m/z= 573.23964-573.24164  
 m/z= 589.23455-589.23655  
 m/z=547.18760-547.18960 
B 
C 
D 
TIC 
5.5 
5.2 
0 
1e+4 
Time (min) 
0 2 4 6 8 10 12 14 
Intensity (cps) 
0 
2e+4 
 m/z=513.21851-513.22051  
 m/z=545.17195-545.17395 F 
G 
E 4.3 
4.5 
6.0 
7.5 
Impact Factor 3.582   Case Studies Journal ISSN (2305-509X) – Volume 4, Issue 6 – June-2015 
http://www.casestudiesjournal.com  Page 44 
 
 
Figure 5: Extracted ion chromatograms (XICs) by LC/ESI-FTICR MS acquired in negative ion mode of ATO solution (a), RST 
solution (b) and in negative and positive ion mode of SIM (c) after one month of biodegradation. The ions monitored are displayed 
in each trace and correspond to the most abundant protonated or deprotonated molecules, [M+H]
+ 
or [M-H]
-
, using a restricted 
window of ±0.0010 m/z unit centered on each selected ion. 
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Figure 6: Chemical structures of Atorvastatin biodegradation products. Ortho, para-dihydroxyatorvastatin, ( 7-
[2-(4-Fluoro-phenyl)-4-(4-hydroxy-phenylcarbamoyl)-5-isopropyl-3-phenyl-pyrrol-1-yl]-3,5-dihydroxy-
heptanoic acid), C33H35FN2O7 with exact m/z 589.23555 (6); para-hydroxy Atorvastatin, (7-[2-(4-Fluoro-
phenyl)-4-(4-hydroxy-phenylcarbamoyl)-5-isopropyl-3-phenyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic 
acid),C33H35FN2O6 with exact m/z 573.24064 (7); 7-[4-(2,4-Dihydroxy-phenylcarbamoyl)-2-(4-fluoro-
phenyl)-3-phenyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid, C30H29FN2O7with exact m/z 547.18860 (8); 7-
[4-(2,4-Dihydroxy-phenylcarbamoyl)-2-(4-fluoro-phenyl)-3 
-phenyl-pyrrol-1-yl]-5-hydroxy-3-oxo-heptanoic acid C30H27FN2O7  with exact m/z 545.17295 (9); 5-(4-
Fluoro-phenyl)-1-(3-hydroxy-5-oxo-pentyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid (4-hydroxy-
phenyl)-amide , C31H31FN2O4 with exact m/z 513.21951 (10), and Simvastatin acid C25H40O6 with exact m/z 
435.27560 (11). 
 
 
Impact Factor 3.582   Case Studies Journal ISSN (2305-509X) – Volume 4, Issue 6 – June-2015 
http://www.casestudiesjournal.com  Page 46 
 
 
 
Figure 7: Time course mineralization of Atorvastatin at 0.1mM initial concentrations in batch culture (Photolysis and 
Photocatalysis) solar (lamps Heraeus TNN 15/32). Experimental conditions: atorvastatin concentration = 0.1mM; [TiO2] = 200mg 
/L; Solar intensity (sunny day) = 400 Wm
2
. 
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Figure 8: (a) The TiO2 solution interface under UV- illumination. (b) Reactions on the TiO2 surface under UV-illumination. 
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Figure 9: Structure of atorvastatin (1) and its photoproducts (12-13) 
Appendix B 
 
Table 1: Methods used and wastewater quality parameters measured in the Al-Quds WWTP. 
Parameter measured 
Instrument used for 
analysis 
Method of analysis Reference 
pH pH-meter 3320, Jenway 
SM#4500-H+(B) (on 
site) 
Direct measurement as 
manufacturer procedure 
APHA 1995, 19
th
 ed. 
[30] 
Conductivity 
Conductivity meter 4320, 
Jenway 
2520-B 
Total Coliforms and 
Fecal Coliforms 
Membrane filter method 
9222-B 
9221-E 
APHA 1995, 19
th
 ed. 
Orthophosphate 
Automated ascorbic acid 
reduction 
SM# 4500-PF APHA 1995, 19
th
 ed. 
COD 
BOD5 
Hach COD reactor 
DO meter – Oxy 197 
5210-B 
5220-D 
APHA 1995, 19
th
 ed. 
NH4
+
 Nesselarization method 4500A-NH3 APHA 1995, 19
th
 ed. 
Total bacterial count 
Pour plate method after 
serial dilutions 
9215D 
APHA 2005, 21
th
 ed. 
[31] 
Solids Gravimetric methods 
2540B 
2540C 
2540D 
APHA 2005, 21
th
 ed. 
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    Table 2: Physical, chemical and biological parameters of wastewater to be treated. 
Parameters Results Units Parameters Results Units 
pH 7.32 ±0.01 ------ TSS 3668 ±6 mg L
-1 
 
Conductivity 2000 ±8 µSm cm
-1
 BOD 915 ±5 mg L
-1 
 
Temperature 15.5 ±0.2 °C COD 1936 ±6 mg L
-1 
 
Turbidity 4960 ±7 NTU NH4-N 59.5 ±0.1 mg L
-1 
 
DO 0.40 ±0.01 mg L
-1
 PO4-P 14.3 ±0.1 mg L
-1 
 
TS 4218 ±8 mg L
-1
 FC (E. coli) 2.9 ×10
5
 ± 0.3×10
5
 cfu/100mL 
TDS 618 ± 4 mg L
-1
 TC 6.5 ×10
6
 ± 1.3×10
6
 cfu/100mL 
Settable solids 240 ± 3 mg L
-1
 TAC  2.6 ×10
7
 ± 1.3×10
7
 cfu/100mL 
a
DO, dissolved oxygen; TS, total solid; TDS, total dissolved solids; TSS, total suspended solids; BOD, biological oxygen 
demand; COD, chemical oxygen demand; FC, fecal coliforms; TC, total coliforms; TAC, total aerobic count. 
 
Table 3: Removal of ATO, RST and SIM from wastewater by different treatment units in Al-Quds WWTP; average values of 
three replicates. 
Sample description 
Sampling site 
as in Figure 
S1 
Concentration of ATO, RST & SIM mg L-1 Removal % 
Means  
S.D. 
Means  
S.D. 
Means  S.D. ATO RST SIM 
The initial concentration of drug in 
storage tank (after addition of 
drug)  
1 1.0 ± 0.17 0.92 ± 0.04 0.97 ± 0.11 
  
 
UF-HF 
influent 2 0.85 ± 0.02 0.78 ± 0.03 0.72 ± 0.06    
brine produced 3 
0.51 ± 0.03 0.397 ± 
0.02 
0.32 ± 0.02 
  
 
effluent 4 
0.13 ± 
0.004 
0.24 ± 
0.001 
0.19 ± 0.004 
84.6 69.2 
73.6 
UF-SW 
brine 5 
0.12 ± 0.02 0.1 ± 0.02 0.097 ± 
0.007 
  
 
effluent 6 
b.l.d. b.l.d. 
0.067 ± 0.02 
≈ 100.0 ≈ 
100.0 
90.7 
GAC  effluent 7 - - b.l.d. - - ≈ 100.0 
b.l.d. = below the limit of detection 
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Table 4: Degradation rates and half-lives of ATO, RST and SIM in sludge and pure water and determination 
coefficients (R²). 
Drug Medium k (s
-1
) Half-life (d) R² 
ATO sludge 2.2 10
-7
 36.3 0.9538 
 water 1.9 10
-8
 433.1 0.9557 
RST sludge 1.8 10
-7
 45.9 0.9962 
 water 2.2 10
-8
 364.7 0.9177 
SIM sludge 1.8 10
-6
 4.4 0.9483 
 water 6.2 10
-7
 12.9 0.9892 
 
 
Table 5: Langmuir adsorption parameters (K and Qmax) and determination coefficients (R²) obtained from the 
adsorption of ATO, RST and SIM on the micelle-clay complex and activated charcoal. 
Drug Adsorbent K (L mg
-1
) Qmax (mg g
-1
) R² 
ATO Micelle-clay complex 10.7 23.2 0.9223 
 Activated charcoal 5.0 9.1 0.9873 
RST Micelle-clay complex 8.2 29.4 0.9408 
 Activated charcoal 7.4 27.3 0.9748 
SIM Micelle-clay complex 8.4 24.4 0.9154 
 Activated charcoal 6.5 11.9 0.9568 
 
Table 6: Removal of ATO, RST and SIM by filtration of 1L of pure water solutions (100, 10, 1.0, 0.01 mg L
-1
) through 
laboratory filtering columns, which included either MC or GAC mixed with excess sand at 1:50 (w/w) ratio; means of three 
replicates. 
Initial concentration 
(mg L
-1
) 
Column type 
a
 
Average eluted concentration  S.D: 
(mg L
-1
) 
ATO RST SIM 
100 MC b.l.d. b.l.d. b.l.d. 
100 GAC 62.2±2.5 50.34.2 52.72.5 
10 MC b.l.d. b.l.d. b.l.d. 
10 GAC 2.80.48 b.l.d. 0.080.03 
1.0 MC b.l.d. b.l.d. b.l.d. 
1.0 GAC 0.250.05 
b.l.d. b.l.d. 
0.01 MC b.l.d. b.l.d. b.l.d. 
0.01 GAC b.l.d. b.l.d. b.l.d. 
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a
Flow rate, 2 mL min
-1
; temperature, 25
 0
C; pH, 7.2 
 b.l.d., below the detection limit of the analytical method used. 
 
Table 7: Kinetic parameters of atorvastatin degradation: n, reaction order; t1/2, half-life; k, kinetic constant; R
2
, determination 
coefficient. Values were obtained on the basis of three replicate experiments. 
Oxidation Process n t1/2 (h) k(h
−1
) R2 
UV 1 1.15 0.165 0.94516 
TiO2/UV 1 5.02 0.704 0.94599 
 
